Robert Sherwin, MD

In Memoriam:

1942-2023

Robert S. Sherwin. MD was the C.N.H. Professor of Medicine in the Section of Endocrinology at Yale School of Medicine in New Haven, CT. He graduated from the Albert Einstein College of Medicine in 1967. After his residency in internal medicine at Mount Sinai Hospital (N Y), he served as a research fellow in metabolism and diabetes at the National Institutes of Health. In 1972 Dr Sherwin moved to Yale School of Medicine where he was a postdoctoral fellow and subsequently was appointed to the faculty in 1974. He served as the Chief of the Section of Endocrinology as well as the Director of the CTSA-funded Yale Center for Clinical Investigation and the NIDDK-funded Diabetes Research Center at Yale. His special clinical interests included patients with type 1 diabetes, intensified insulin therapy, complicated type 2 diabetes patients, and hypoglycemia associated with diabetes. Dr Sherwin’s research activities spanned clinical and basic research and were focused on brain glucose sensing mechanisms mediating the activation of counter-regulatory responses and the impact of hypoglycemia and insulin on brain function and metabolism as well as the changes in brain function that drive disordered glucose control and eating behavior using brain imaging techniques (fMRI, spectroscopy, and PET) in both diabetes and obesity. Dr. Sherwin had served as President of the American Diabetes Association and as a member of the FDA Advisory Committee for Endocrinologic and Metabolic Drugs. He had served as the Chairman of the Medical Science Advisory Board of the JDRF and on the editorial boards of leading diabetes and endocrine journals. He had published over 400 articles in peer-reviewed journals and is the recipient of numerous scientific awards including the American Diabetes Association’s Banting Award for lifetime scientific achievement, the Novartis Award for long-standing achievement in diabetes, and 2 MERIT Awards from the NIH.